Alpha-fetoprotein (AFP) is a major embryo-and tumor-associated protein capable of binding and transporting variety of hydrophobic ligands including estrogens. AFP has been shown to inhibit estrogen receptor (ER)-positive tumor growth and this can be attributed to its estrogen-binding ability. Despite AFP has long been investigated, its three-dimensional (3D) structure has not been experimentally resolved and molecular mechanisms underlying AFPligand interaction remain obscure. In our study we constructed homology-based 3D model of human AFP (HAFP) with the purpose to perform docking of ERα ligands, three agonists (17βestradiol, estrone and diethylstilbestrol) and three antagonists (tamoxifen, afimoxifene and endoxifen) into the obtained structure. Based on ligand docked scoring function, we identified three putative estrogen-and antiestrogen-binding sites with different ligand binding affinities.
Introduction
Alpha-fetoprotein (AFP) is a major mammalian embryo-specific and tumor-associated protein recognized as a "golden standard" among cancer biomarkers used in clinical practice [1] .
AFP gene is expressed during embryonic development by liver and yolk sac and is downregulated soon after the birth to be re-expressed in adult patients with hepatocellular carcinoma (HCC) [2] [3] [4] . Biological roles of AFP during embryonic development and tumor growth have long been investigated however remain not fully understood [5] . Experimental data evidence capability of both native and recombinant AFP of regulating cell proliferation and immune response, and binding and transporting variety of hydrophobic ligands such as estrogens, fatty acids and drugs suggesting that these functions have a role during embryo-and carcinogenesis [6] [7] [8] [9] [10] .
High maternal serum AFP concentration during second and third trimesters of pregnancy has been shown to correlate with reduced breast cancer risk [11] . Estrogen-binding capability of AFP can contribute to decrease in concentration of free active forms of estrogens below the levels necessary to activate estrogen receptors (ERs), ERα and ERβ, in target cells. Indeed, AFP has been reported to inhibit estrogen receptor (ER)-positive human MCF-7 and MTW9A rat mammary cancer growth, and this associated with interaction of AFP with 17β-estradiol [12, 13] .
Moreover, synthetic human AFP-derived peptides can cause both inhibition of uterine estrogendependent cell proliferation and simultaneous increase in anti-tumor effect of tamoxifen [14] .
Canonical estrogen-signaling pathway starts from ligand binding to ERs, which causes conformational changes, dimerization and activation of the receptor. Further, the activated receptor-hormone complex is translocated into the nucleus, where it binds to specific sequences of estrogen responsive element (ERE) in the promoter region of target genes [15] . ERs recruit variety of co-regulatory proteins, co-activators and co-repressors, which can cause alterations in hormone-receptor complex formation, DNA-binding abilities [16] .
Natural estrogen, 17β-estradiol (E2) is the most potent female sex steroid hormone as compared to its metabolites, estrone (E1) and estriol (E3), in regulating cell proliferation, differentiation and homeostasis in reproductive, skeletal, cardiovascular and neural tissues [17] [18] [19] [20] . However, various endocrine disruptors can exert structural similarity to steroid hormones and can directly interfere with estrogens for their ER-binding sites [21] . Estimation of binding affinities of 125 ER ligands, both natural and chemically synthesized, performed using competitive ligand-binding assay demonstrated, that certain structural features of estrogens such as the presence of aromatic ring may be important for their binding efficacy to ERs [22] .
While estrogens are considered as ER agonists, numerous selective estrogen receptor modulators (SERMs) can serve both as ER agonists and antagonists, in a tissue-or promoterspecific and dose-dependent manner [23, 24] . Among SERMs, tamoxifen is the most commonly used anti-tumor non-steroidal drug for breast cancer therapy. Tamoxifen, and its derivatives, afimoxifene (4-hydroxytamoxifen, 4OHT) and endoxifen (4-hydroxy-N-desmethyl-tamoxifen), belong to type 1 antiestrogens, which can act as both agonists and antagonists [25] . Structurally, tamoxifen is similar to diethylstilbestrol (DES), synthetic non-steroidal estrogen and pure agonist recognized as teratogen and carcinogen. However, unlike DES, tamoxifen has additional aromatic ring and a side chain (trans-isomer) with N-linked methyl groups [26] . Afimoxifene and endoxifen are key active metabolites of tamoxifen and experimentally have been shown to possess higher affinity and specificity to ERα as compared to tamoxifen [27] .
The ability of hormone-binding transport proteins to interfere with ER-ligand interactions dictates the importance of investigation of binding affinities of both estrogens and ER disruptors not only to ERs, but also to estrogen-binding transport proteins such as AFP. Rodent AFPs have been experimentally evidenced to bind free estrogens, while human AFP (HAFP) has been shown to bind only immobilized estrogens [28, 29] . Using chimeric human-rat AFP the existence of two types of estrogen-binding sites, high-affinity and low-affinity, in rat AFP has been proposed [30, 31] . However, there is no experimentally obtained 3D structure of AFP for any biological species in PDB database, both with and without ligands. This dictates the necessity to create 3D model of AFP followed by molecular docking of ligands into the obtained structure to investigate AFP-ligand binding affinities and mechanisms underlying protein-ligand interactions at atomic level. This might contribute to understanding a role of estrogen and antiestrogen binding to transport proteins in functioning of endocrine system both in normal and pathologies.
HAFP contains 609 amino acid residues and is composed of three homologous domains: I (aa 19-210), II (aa 211-402) and III (aa 402-601). It belongs to the family of serum albumin (SA), which includes except SA and AFP two more proteins: alpha-albumin (afamin) and vitamin Dbinding protein (VTDB). Members of this family are localized in tandem arrangement in the q11-q13 region of chromosome 4 and share high degree of sequence similarity [32] . Sufficient degree of sequence identity (up to 40%) between AFP and SA makes it possible to construct 3D model of AFP based on homology with SA, for which experimentally obtained crystal structures can be found in PDB database. Earlier, our group used this approach to build 3D structure of HAFP by homology-based modeling and to investigate HAFP-binding modes of DES, validated estrogen disruptor [33] .
Later, Shen and co-workers built 3D structure of rat AFP using homology-based modeling to elucidate protein-ligand binding modes for representative AFP binders and to estimate binding affinities of variety estrogens and estrogen disruptors [34] . The ability of rat AFP to undergo conformational changes during ligand binding and to accommodate numerous structurally and physicochemically diverse compounds has been observed. Additionally, testing rat AFP binding of a large set of structurally diverse chemical compounds revealed 53 binders from 13 structural categories and 72 non-binders [35] .
In the present study, we performed homology-based modeling of 3D structure of HAFP with the aim to perform molecular docking of three ER agonists and three antagonists to the obtained model with the aim to elucidate binding modes and structures of estrogen-and antiestrogenbinding sites. MM/GBSA rescoring method based on molecular dynamics (MD) simulation was exploited to assess affinities of estrogens to HAFP as compared to affinities of antiestrogens.
Further we performed in silico point substitutions of amino acid residues, presumably, involved in estrogen binding to confirm their roles in protein-ligand interactions. We found that there are three principal estrogen-and antiestrogen-binding sites in HAFP. Two of them are high-affinity sites located in a hollow tunnel formed within subdomains IB and IIA and in opposite side of the molecule in a groove originating from a cavity formed by U-shaped AFP structure in accordance with experimental data [36] . The third is low-affinity binding site located at the bottom of the cavity. Investigation of geometries of the binding sites allowed elucidating amino acid residues involved in HAFP-ligand binding and types of HAFP-estrogen and HAFP-antiestrogen interactions. We showed that antiestrogens have higher affinity to HAFP as compared to estrogens, both natural and synthetic, and this may be dictated by differences in their structures and amounts of rotameric states.
Results
The overall architecture and quality of constructed HAFP 3D model Figure 1A ) between sequences of target protein, HAFP retrieved from Uniprot knowledge base (ID: P02771), and HSA identified as the best template for homology-based modeling and retrieved from PDB database (ID: 1E78) showed identity degree to be equal to 39%, and secondary structure elements (SSE) to be represented by α-helices and random coils with no βstrands in accordance with experimental data [36] . Validation of constructed in our study 3D model of HAFP structure showed good quality and reliability of the obtained model. Ramachandran maps generated by PROCHECK program verified proper stereo-chemical and conformational properties of amino acid residues in the modeled HAFP structure ( Figure 1B) . Indeed, 92.7% of all residues were located in favored regions, while 6.8% of all residues were in additional allowed regions, and two residues, Ser84 and Glu565, were in generously allowed regions; only one residue, Ala39, occurred in disallowed region.
Relaxation and optimization of constructed HAFP model with the use of 200 ns MD simulation showed its sufficient stability. Indeed, RMSD values calculated for Cα-atoms for the optimized HAFP structure were stabilized around 3.8-4.0 Å ( Fig 1C) . RMSF plots obtained for residues in HAFP sequence allowed judging about local fluctuations, which were not high and correspond to regions with irregular structures and loops ( Figure 1D ). Additionally, high quality of the model was confirmed by analysis of SSE composition for each trajectory frame, which showed its stability during the all 200 ns MD simulation ( Figure 1E ). Furthermore, structural alignment score of the obtained structure against the used template, 1E78, was quite low, 0.002, along with RMSD equal to 0.196 Å. Superimposition of HAFP models before and after 200 ns MD simulation showed that the optimized structure becomes more relaxed and expanded.
Analysis of stereo-chemical parameters of the obtained structure ( Figure 1F ) showed that all residues have correct Cα-chirality, while only 1.2% residues have incorrect absolute deviation from mean χ1 value and 5% residues from mean ω torsion. Estimation of water accessibility areas showed that α-helical regions are, mostly, buried indicating their enrichment in hydrophobic residues necessary for interaction with variety of hydrophobic ligands. Additionally, G-factor values for the overall structure and the main chain bonds and angles along with combination of φ-ψ, χ1-χ2, χ3-χ4 correspond to good quality of the model obtained in this study and its reliability for further usage.
Analysis of the HAFP model architecture showed its U-shaped structure, in which three domains and secondary structure elements represented by α-helices can be identified ( Figure 2A ).
Additionally, visualization of the model surface by Maestro suite in Schrödinger software revealed inter-domain cavity formed by HAFP domains I and III and a tunnel ( Figure 2B ) located between its subdomains IB and IIA. This tunnel has a length of about 29.3 Å and diameters from about 9.25 Å in its narrow part to 15.24 Å in its wide segment. Furthermore, a groove originated from the cavity ( Figure 2C ) formed between domains I and III may be observed at the back side of HAFP surface. 
HAFP-ligand docked poses
Docking procedure was performed to search for possible positions of 6 ligands, 3 estrogens and 3 antiestrogens ( Figure 3 ), in HAFP potential binding sites and to estimate the ligand binding affinities. Optimized ligand molecules extracted from Pubchem database were docked into the optimized HAFP modeled structure using flexible docking protocol to enable search for all probable conformations generated due to changes in residue torsion angles. In total, 84 ligand-docked complexes were obtained based on 10 predicted by SiteMap potential binding sites. Based on calculation of ligand docked scoring functions, we elucidated sites that best accommodate ligands and selected ligands with best binding affinities (Table1). Visualization of these complexes allowed identifying three most potent estrogen-and antiestrogen-binding sites, which we designated as A and B, and C ( Figure 4A -C). Site A was located in a tunnel formed between subdomains IB and IIA, while site B was at the bottom of cavity in U-shaped HAFP structure, and site C was in a groove originated from the cavity and located on the back side of HAFP molecule. Ligand docked scoring functions indicated sites A and C to have higher affinity in relation to all ligands, both estrogens and antiestrogens, as compared to site B. To confirm this and to identify dynamic HAFP-ligand binding modes and ligand binding affinities, we further carried out 100 ns MD simulation study of the 12 best protein-ligand complexes selected on the basis of the ligand docked scoring functions. 
Binding of ligands to HAFP studied by MD simulation

Stability of HAFP-ligand complexes
Estimation of stability of HAFP-ligand complexes was made based on protein-ligand RMSD calculations. Figure 5C ). Affinity of endoxifen to HAFP was high in all three sites, being the best in site A (Table 2 ), in which protein-ligand RMSD remains stable during 100 ns MD simulations ( Figure 5D ). The best HAFP-afimoxifene and HAFP-tamoxifen complexes were in site C
showing enough stability during 100 ns MD simulation ( Figures 5E and 5F ). 
Ligand binding affinities
To assess ligand binding affinities MM/GBSA rescoring method based on 100 ns MD simulation was implemented. For this purpose, we calculated MM/GBSA values for each of protein-ligand RMSD snapshots obtained during 100 ns MD simulation and then calculated average MM/GBSA values for each trajectory. Table 2 and His483 to Lys138, Phe172 and Lys453 ( Figure 6C ) keeping, however, the same types of interaction. HAFP-endoxifen contacts in the same site were maintained by Leu138, Arg169, Ser217, and Lys543 residues ( Figure 6D) . In site C, HAFP-afimoxifene binding was provided, mostly, by Thr132, Phe172, Gln221, Lys228 residues, which keep contacts with the ligand during half and more of MD simulation ( Figure 6E ). As for HAFP-tamoxifen interaction in this site, in addition to Phe172, Lys129 instead of Lys228 and disulfide bond Cys224-Cys270 were involved ( Figure 6F ). Additionally, ligand-centered interaction maps were generated to indentify types of noncovalent interactions between functional groups of a ligand and a definite amino acid residue in HAFP. Figure 7A illustrates that HAFP-E2 interactions in site B are provided, mostly, by Hbonds between Gln221 and Ser217 to E2 OH-group at C17-atom along with π-cation interaction between aromatic A-ring of E2 and positively charged ε-amino group of Lys453. Water-bridge between Lys453 and OH-group at C3-atom of estrone and hydrophobic pocket of Leu138 and
HAFP-ligand interaction modes
Phe172 are important in HAFP-E1 interaction in the same site ( Figure 7B ). In site A, DES interacts by its two OH-groups with Asp478 and Thr239 residues through water-bridges, and by its aromatic ring forms π,π-stacking to His222 supported by hydrophobic pocket consisted of Phe235 and Ile479 ( Figure 7C ). Endoxifen involves its side chain + NH2-group for H-bonding with Ser216 and His316. Additionally, it interacts with Cys269-Cys277 disulfide bond and hydrophobic pocket of Val262, Leu278 residues in the binding site ( Figure 7D ).
Afimoxifene interacts with HAFP, mostly, through its aromatic ring, which is involved in πstacking interactions with Phe172 and Cys224-Cys270 disulfide bond in site C. Additionally, the ligand OH-group is involved in water-mediated H-bonding and Gln221 and Glu489, while its side chain NH + -group can form salt bridges, H-bonds and water bridges with Glu267 ( Figure 7E ).
Tamoxifen interactions with site C were provided, mostly, by π-cation and π,π-stacking bonds to Phe172 or Lys129 as well as hydrophobic interactions with Cys224-Cys270 disulfide ( Figure   7F ). Figure 8A ). However, diffusion of the ligand from its binding pose in site B resulted from Gln221Val substitution was observed ( Figure 8B) indicating that Gln221 has a key role in HAFP-E2 interaction. To confirm the roles of amino acid residues in HAFP-estrone binding we performed the replacement, which caused re-arrangement of DES in the binding site ( Figure 8D ).
Effects of in silico point amino acid substitutions
All substitutions in HAFP-endoxifen complex resulted in increase in ΔGbind values (Table 3) indicating key roles of all replaced residues as well as Cys269-Cys277 disulfide bond in proteinligand interactions. However, visualization of the complexes showed that ( Figure 8E ) only Lys453Glu substitution in site B caused ligand diffusion from its binding site suggesting a key role π-cation interaction between Lys453 side chain and two aromatic rings of endoxifen. All substitutions performed for HAFP-afimoxifene and HAFP-tamoxifen complexes in site C also caused decrease in binding affinities, except Lys228Leu, which improved affinity of afimoxifene binding to HAFP. Upon Lys228Leu replacement π-cation interaction was replaced by π,πstacking between aromatic rings of Phe172 and afimoxifene, and this indicates a key role of Phe172. Visualization of afimoxifene binding in site C showed that both Cys224Ala and Phe172Ala substitutions caused escape of the ligand from its binding site confirming key roles of both Phe172 and Cys224-Cys270 disulfide in the interaction ( Figure 8F ).
Discussion
There are sufficient identity degrees between HAFP and HSA being up to 40% between their full length sequences and about 31, 41 and 47% between their domains I, II and III, respectively. This makes it possible to construct 3D model of HAFP based on homology with HSA, for which numerous experimentally resolved structures can be found in PDB data base.
Validation of HAFP 3D model structure created in our study on the basis of homology to HSA showed its high quality and reliability enabling its usage for molecular docking of 6 ligands, three estrogens and three antiestrogens, to identify their binding modes and affinities to the protein. Importantly, identity degree between HAFP and HSA domains II and III, where principal ligand binding sites are located, are sufficiently higher than that for their domains I.
Earlier we reported construction HAFP 3D model structure using Modeller software and based on homology with the same template, HSA, PDB ID 1E78 [33] . In our previous work we ΔGexp calculated based on experimentally obtained rodent AFP-estrogen binding Ka values (S1 and S2 Tables) evidence that 17β-estradiol has the highest binding affinity, and DES has the lowest affinity to both rat and mouse AFPs.
We calculated binding free energy values with the use of MM/GBSA rescoring method based on 100 ns MD simulation, which showed that HAFP-binding affinities of all estrogens were lower than those of antiestrogens, being highest for HAFP-endoxifen complex in site A and HAFP-afimoxifene complex in site C. Ligand efficiencies were also highest for the same complexes, being lower for estrogens as compared to antiestrogens. Analysis of MM/GBSA
ΔGbind energy terms showed that binding of estrogens to HAFP is provided, mostly, by van der Differences in the affinities of estrogens and antiestrogens can be explained by some distinctions in their structures along with amounts of their rotational bonds (Figure 1 and Table1).
Rigid structure of estrogens that contain four condensed rings determines worse scoring functions as compared to antiestrogens, which are composed of three aromatic rings linked by relatively flexible hydrocarbon linker. The best docked pose among antiestrogens observed for endoxifen can be explained by its distinct structural features such as the presence of OH-group at C4-position, which is lacked in tamoxifen, and by the absence of second N-linked CH3-group that exists in afimoxifene.
To confirm the roles of definite amino acid residues in HAFP-ligand interactions revealed by ligand docking and subsequent 100 ns MD simulation we performed in silico point amino acid substitutions. This allowed proposing amino acid residues, which can have key roles in binding of estrogens and antiestrogens to HAFP. Generally, point amino acid substitutions do not trigger changes in most dihedral angles in a protein and, subsequently, the entire protein conformation [43, 44] .
Accuracy in prediction of a role of residue substitutions in protein functions depends on residue properties such as size, hydrophobicity, charges, i.e. its type and microenvironment. In our study, we revealed that replacement of amino acid residue involved in protein-ligand interaction allows conserving the same type of interaction by ligand movement to another residue with the same physicochemical properties. This can be achieved through the ligand movement to another residue with the same physicochemical properties.
Conclusions
In our study, we showed that three major binding sites differed by values of their binding free energies can be distinguished in HAFP. Homology-based modeling, molecular docking and MD simulation studies allowed elucidating topology of the protein surface and geometries of protein ligand-binding sites along with amino acid residues involved in HAFP-ligand interactions. Point substitutions of the residues performed in silico allowed distinguishing those residues that can have key roles in HAFP-ligand binding. Our results are in agreement with previously obtained experimental data; however, further investigations using novel experimental approaches are required to confirm our findings.
Materials and methods
HAFP homology-based modeling
To perform computational HAFP homology-based 3D model construction we used a highly accurate fully-integrated Prime protein structure prediction suite of programs in Schrödinger software [45] with application of Maestro graphical interface suite [46] .
Template identification
PDB [47] database was searched for experimentally obtained 3D structures of SA family proteins to be used as potential templates for HAFP 3D model building. HAFP sequence (ID: P02771) was retrieved in FASTA format from Uniprot knowledge base [48] and aligned to primary structures of candidate templates using BLAST algorithm [49] . Crystal structure of human SA (HSA) obtained at resolution of 2.6 Å (PDB ID: 1E78) was selected as the best template with sequence identity of 39% to HAFP. The edition of the target-template alignment was performed using Prime STA method and secondary structure elements were predicted using SSpro utility applied in Prime package, version 5.2.
Model generation and validation
3D model of HAFP structure was generated with the use of Protein Preparation Wizard [50] in Schrödinger software, version 2018-2. Quality and accuracy of the obtained model was validated used several methods including residue-by-residue geometry and stereochemistry assessment based on Ramachandran analysis with the implementation of PROCHECK algorithm [51] .
Further, the generated model underwent refinement procedure in which any inconsistencies in the obtained structure such as incorrect bond orders, missing hydrogen atoms, and orientation of different functional groups in amino acids were checked and corrected. The model was optimized and minimized to reach the converged root mean square deviation (RMSD) of 0.30 Å with application of OPLS3e force field [52] . Additionally, to evaluate stability of the constructed model we performed RMSD and RMSF calculations for the protein backbone and Cα atoms along 200 ns MD simulation trajectory.
Model relaxation and optimization
The constructed model was subjected to optimization process during 200 ns MD simulation with application of OPLS3e force field in explicit water environment generated using TIP3P
water model. For MD simulation Desmond program package, version 5.4 [53] , using Maestro suite, version 11.6, in Schrödinger software, version 2018-2, was implemented. MD simulation was carried out in periodic boundary conditions created using orthorhombic box, sizes of which were calculated by buffer method at distances of 10 Å along each dimension. The simulation system was electrostatically neutral in 0.15 M NaCl solution to provide physiological isoosmotic environment. Normal pressure temperature (NPT) ensemble with implication of Nose-Hoover thermostat [54] to maintain constant temperature equal to 310 K and
Martyna-Tobias-Klein barostat [55] at 1.01325 bar pressure were implemented. Cut-off radii of 9.0 Å were set for short-range Coulomb interactions. The recording interval for each frame was equal to 10 ps resulting in total of 20,000 recorded frames.
Molecular docking and scoring Ligand preparation
Structures of ligands used in this work (Figure 1 
Identification of protein ligand-binding sites and grid generation
SiteMap suite [59] in Schrödinger software, version 2018-2, was exploited for accurate identification and evaluation of probable binding sites in HAFP. Receptor Grid Generation suite in Schrodinger software, version 2018-2, was implemented for generation of docking grid that was centered to cover all predicted by SiteMap protein-ligand binding sites. Van der Waals radii were scaled to 1.0 Å with a partial cut-off distance of 0.25 Å to soften energy potential for nonpolar parts of the receptor, while other atoms were free of scaling. Then, counter maps were generated to analyze hydrophobic and hydrophilic surfaces of the active sites.
Docking protocol
Ligand docked poses were generated by searching the most populated conformations for each protein-ligand complex. Schrödinger Glide suite, version 7.9, [60] with extra precision ligand docking protocol was employed to implement HAFP-ligand docking followed by calculation of scoring functions. Here, ligands were sampled as flexible, while the conformer generation procedure included (non-ring) nitrogen inversions and ring conformations.
Scoring functions
To evaluate ligand docked poses, scoring functions calculated with many approximations were used. We assessed docked protein-ligand complexes using extra precision Glide score (XPG Score) tool [61] , which enables calculating gscore and emodel scoring functions. Proteinligand complexes with the best scoring functions were selected for further MD simulation.
MD simulation of protein-ligand complexes
The final ligand docked poses with the best scoring functions were subjected to 100 ns MD simulation in explicit water environment generated using TIP3P water model. Schrödinger 
Protein and ligand RMSD and RMSF calculation
To assess conformational stability of the modeled protein structure during MD simulation, RMSD calculations for protein backbone and Cα atoms were implemented. RMSD analysis was also used to get an insight into conformational changes during protein-ligand interactions with and without amino acid substitutions. Analysis of ligand RMSD when it is in protein-ligand complex was performed to judge about stability of the ligand in its binding site and its ability to diffuse from the binding site during MD simulation or as a result of an amino acid substitution.
To characterize local changes along the protein polypeptide chain during MD simulation and residue-by-residue fluctuations in HAFP molecule during its interaction with a ligand, calculations of root mean square fluctuation (RMSF) were made [62] . Protein RMSF plots were superimposed on secondary structure elements to evaluate their stability.
In silico point amino acid substitutions
To confirm the roles of amino acid residues involved in HAFP-ligand interactions we MM/GBSA rescoring was performed for initial ligand-docked poses with best scoring functions and for each protein-ligand complex during 100 ns MD simulation with and without amino acid substitutions in ligand-binding sites. In total, 1000 snapshots were generated from each MD simulation trajectory and average ΔGbind values were calculated [66] . The free energy changes of during proteinligand interactions were calculated with the use of OPLS3e force field and the VSGB solvent model.
Before calculations all counter ions and water molecules were deleted from each system.
Binding free energy values were calculated according to the following equation (1) 
where n is amount of ligand heavy atoms.
To calculate experimental binding free energies (ΔGexp) dissociation constant (Kd) or IC50
values obtained from literature data were used. ΔGexp was assessed as follows (4) DES 0.2 x 10 7 5.00 x 10 -7 -8.592 [40] 
